The prognostic significance of heart rate for cardiovascular disease and hypertension

Current Hypertension Reports

Volumn 12, Issue 3, 2010, Pages 162-169

  Tjugen, Trygve B ^a,b   Flaa, Arnljot ^a   Kjeldsen, Sverre E ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Halfdan Wilhemsens Allé 17   (Norway)

Author keywords

Blood pressure; Cardiovascular disease; Cardiovascular risk; Catecholamines; Heart rate; Hyperkinetic state; Hypertension; Sympathetic overactivation

Indexed keywords

ADRENALIN; CATECHOLAMINE; NORADRENALIN;

BLOOD PRESSURE; BORDERLINE HYPERTENSION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; ESSENTIAL HYPERTENSION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART OUTPUT; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; PATHOGENESIS; PROGNOSIS; REVIEW; SUDDEN DEATH; SYMPATHETIC TONE;

EID: 77956395163     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-010-0104-8     Document Type: Review

References (46)

1. Goldring W, Chassis H: Antihypertensive therapy: an appraisal. Arch Intern Med 1965, 115:523-525.
2. Levy RL, White PD, Stroud WD, et al.: Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA 1945, 129:585-588.
3. Gillmann MW, Kannal WB, Belanger A, et al.: Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J 1993, 125:1148-1154.
4. Kannel WB, Wilson P, Blair SN: Epidemiologic assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J 1985, 109:876-885.
5. Kannel WB, Kannel C, Paffenbarger RS Jr, et al.: Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987, 113:1489-1494.
6. Dyer A, Persky V, Stamler J, et al.: Heart rate as a prognostic factor for coronary heart disease and mortality findings in three Chicago epidemiological studies. Am J Epidemiol 1980, 112:736-749.
7. Gillum RF, Makuc DM, Feldman JJ: Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1991, 121:172-177.
8. Benetos A, Rudnichi A, Thomas F, et al.: Influence of heart rate on mortality in a French population: role of age, gender and blood pressure. Hypertension 1999, 33:44-52.
9. Kristal-Boneh E, Silber H, Harari G, et al.: The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow up of 3527 male Israeli employees (the CORDIS study). Eur Heart J 2000, 21:116-124.
10. Rabin S,Mathewson F, Rate F: Relationship of blood pressure in 20- 39 year old men to subsequent blood pressure and incidence of hypertension over a 30-year observation period. Circulation 1973, 65:291-300.
11. Julius S, Jamerson K, Mejia A, et al.: The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study. JAMA 1990, 264:354-358.
12. Leitschum M, Cupples LA, Kannel W, et al.: High normal blood pressure progression to hypertension in the Framingham study. Hypertension 1991, 17:22-27.
13. Post WS, Larson MG, Levy D: Hemodynamic predictors of incident hypertension: the Framingham study. Hypertension 1994, 24:585-590.
14. Selby JV, Friedman GD, Quesensberry P: Precursor of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol and other serum chemistries. Am J Epidemiol 1990, 131:1017-1027.
15. Stem MP, Morales PA, Hafner SM, et al.: Hyperdynamic circulation and insulin resistance syndrome ('syndrome X'). Hypertension 1992, 20:802-808.
16. Kim JR, Kiefe CI, Liu K, et al.: Heart rate and subsequent blood pressure in young adults. The CARDIA study. Hypertension 1999, 33:640-646.
17. Widimsky J, Fejfarova MH, Fejfar Z: Changes in cardiac output in hypertensive disease. Cardiologia 1957, 31:381-389.
18. Julius S, Pascual AV, London R: Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation 1971, 44:413-418.
19. Julius S, Pascual AV, Sannerstedt R, et al.: Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation 1971, 43:382-390.
20. Julius S: Borderline hypertension: epidemiologic and clinical manifestation. In Hypertension: Pathophysiology and Treatment. Edited by Genest J, Loiw E, Kuchel O. New York: McGraw-Hill; 1977:630-640.
21. Messerli FH, Frolich ED, Suarez DH, et al.: Borderline hypertension: relationship between age hemodynamics and circulating catecholamines. Circulation 1981, 64:760-764.
22. Julius S, Krause L, Schork N, et al.: Hyperkinetic borderline hypertension in Tecumseh, Michigan. J Hypertens 1991, 9:77-84.
23. Kjeldsen SE, Schork NJ, Leren P, et al.: Arterial plasma norepinephrine correlates to blood pressure in middle-aged men with sustained essential hypertension. Am Heart J 1989, 118:775-781.
24. Stamler J, Berkson DM, Dyer A, et al.: Relationship of multiple variables to blood pressure-findings from four Chicago epidemiologic studies. In Epidemiology and Control of Hypertension. Edited by Oglesby P. New York, London: Stratton Intercontinental Medical Book Corporation; 1975:307-352.
25. Casiglia E, Zamboni S, Mormino P, et al.: Hypertension, glycaemia and blood lipids in a general population. Eur Heart J 1989, 10:815-820.
26. Staessen JA, Fagard R, Amery A: Life style as a determinant of blood pressure in the general population. Am J Hypertens 1994, 7:685-694.
27. Paffenbarger RS, Thorne MC, Wing AL: Chronic disease in former college students. VII.I. Characteristics in youth predisposing to hypertension in later years. Am J Epidemiol 1968, 88:25-32.
28. Garrison RJ, Kannel WB, Stokes J, Castelli WP: Incidence and precursors of hypertension in young adult. The Framingham Offspring Study. Prev Med 1987, 16:235-251.
29. Palatini P, Dorigatti F, Zaetta V, et al.: Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension: the HARVEST Study. J Hypertens 2006, 24:1873-1880.
30. Inoue T, Iseki K, Iskei C, et al.: Higher heart rate predicts the risk developing hypertension in normotensive screened cohort. Circ J 2007, 71:1755-1760.
31. Flaa A, Eide I, Kjeldsen SE, et al.: Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study. Hypertension 2008, 52:336-341. This article concludes that the sympathetic nervous system probably plays a key role in the pathogenesis of essential HT and that elevated HR may represent sympathetic overactivation.
32. Strand AH, Gudmundsdottir H, Os I, et al.: Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years. J Hypertens 2006, 24:905-913.
33. Palatini P: Heart rate as an independent risk factor for cardiovascular disease. Drugs 2007, 67(Suppl 2):3-13.
34. Mancia G, De Backer G, Dominiczak A, et al.; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007, 25:1105-1187. This article represents the first international consensus to consider elevated HR a risk factor for development of CVD and H.T.
35. Palatini P, Benetos A, Julius S: Impact of increased heart rate on clinical outcomes in hypertension. Implications for antihypertensive drug therapy. Drugs 2006, 66:133-144.
36. Palatini P, Julius S: Heart rate and the cardiovascular risk. J Hypertens 1997, 15:3-17.
37. Jamerson KA, Julius S, Gudbrandsson T, et al.: Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993, 21:618-623.
38. Jamerson KA, Smith SD, Amerena JV: Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction. Hypertension 1994, 23:1006-1011.
39. Deibert DC, DeFronzo RA: Epinephrine-induced insulin resistance in man. J Clin Invest 1980, 65:717-721.
40. DiBona GF, Kopp UC: Neural control of renal function. Physiol Rev 1997, 77:75-197.
41. DiBona GF: Neural control of the kidney: past, present and future. Hypertension 2003, 41:621-624.
42. Folkow B: Physiological aspects of essential hypertension in humans. Physiol Rev 1982, 62:347-504.
43. Folkow B: Early structural changes in hypertension: pathophysiology and clinical consequences. J Cardiovasc Pharmacol 1993, 22(Suppl 1):1-6.
44. Mulvany MJ, Aalekjær C: Structure and function of small arteries. Physiol Rev 1993, 73:725-764.
45. Mulvany MJ: Are vascular abnormalities a primary cause or secondary consequence of hypertension? Hypertension 1991, 18 (Suppl 1):52-57.
46. Julius S: The blood pressure seeking properties of the central nervous system. J Hypertens 1998, 6:177-185.